Flagship Pioneering Fund Vi General Partner Llc - Net Worth and Insider Trading

Over the past 18 months, Flagship Pioneering Fund Vi General Partner Llc made no insider transaction in Seres Therapeutics Inc (MCRB). Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 17,204 shares made by David S. Ege , a net sale of 22,536 shares made by Eric D. Shaff , and a net sale of 9,571 shares made by Moltke Lisa Von .

In summary, during the past 3 months, insiders sold 6,901 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 6,901 shares. During the past 18 months, 85,089 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 85,089 shares.

Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Pioneering Fund Vi General Partner Llc made no insider transaction in Sana Biotechnology Inc (SANA). Other recent insider transactions involving Sana Biotechnology Inc (SANA) include a net sale of 949,000 shares made by Flagship Ventures Fund V, L.p. , a net purchase of 1,818,181 shares made by Arch Venture Fund X Overage, L.p. , and a net purchase of 1,818,181 shares made by Keith Crandell .

In summary, during the past 3 months, insiders sold 25,000 shares of Sana Biotechnology Inc (SANA) in total and bought 0 shares, with a net sale of 25,000 shares. During the past 18 months, 1,049,000 shares of Sana Biotechnology Inc (SANA) were sold and 5,454,543 shares were bought by its insiders, resulting in a net purchase of 4,405,543 shares.

Sana Biotechnology Inc (SANA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Pioneering Fund Vi General Partner Llc made no insider transaction in Omega Therapeutics Inc (OMGA). Other recent insider transactions involving Omega Therapeutics Inc (OMGA) include a net sale of 40,000 shares made by Richard A Young , and a net purchase of 3,323,310 shares made by Flagship Pioneering Special Opportunities Fund Ii General Partner Llc .

In summary, during the past 3 months, insiders sold 0 shares of Omega Therapeutics Inc (OMGA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,000 shares of Omega Therapeutics Inc (OMGA) were sold and 3,323,310 shares were bought by its insiders, resulting in a net purchase of 3,283,310 shares.

Omega Therapeutics Inc (OMGA)'s detailed insider trading history can be found in Insider Trading Tracker table.